Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer

Beth Israel Medical Center, New York

Magee Womens Hospital, Pittsburgh

Breast Care Specialists, P.C., Allentown

Virginia Oncology Associates, Norfolk

Advanced Breast Care, Marietta

Advanced Medical Specialties, Miami

Advantage Clinical Research, Nashville

Tennessee Breast Specialists, Nashville

Breast Clinic of Memphis, Germantown

Aurora Sinai Medical Center, Milwaukee

Missouri Cancer Associates, Columbia

OU Medical Center, Oklahoma City

Dallas Surgical Group, Dallas

Leading Edge Research, PA, Dallas

Texas Oncology - Dallas Presbyterian Hospital, Dallas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

Texas Oncology - Tyler, Tyler

Texas Oncology - Bedford, Bedford

Southlake Oncology, Southlake

Texas Oncology - Memorial City, Houston

Cancer Care Centers of South Texas, San Antonio

Comprehensive Cancer Centers of Nevada, Henderson

Breast Care, Las Vegas

USC/Norris Comprehensive Cancer Center, Los Angeles

Breastlink Medical Group, Inc, Long Beach

Willamette Valley Cancer Institute and Research Center, Springfield

Morristown Memorial Hospital, Morristown

Women & Infants Hospital, Providence